Select Page

New Daily Pill Offers Hope for Pancreatic Cancer

A promising new treatment could transform outcomes for people facing advanced pancreatic cancer, one of the toughest cancers to beat. In a major clinical trial, the daily pill daraxonrasib nearly doubled average survival time compared with standard chemotherapy,...
Colon cancer breakthrough

Colon cancer breakthrough

A groundbreaking clinical trial, NEOPRISM-CRC, led by researchers at University College London (UCL) and University College London Hospitals (UCLH), has demonstrated remarkable efficacy of pre-surgical immunotherapy in patients with stage II or III...